The expression of c-erbB-1 and c-erbB-2 in Iranian patients with gastric carcinoma

Pathol Oncol Res. 2002;8(4):252-6. doi: 10.1007/BF03036740. Epub 2003 Feb 11.

Abstract

To assess the significance of epidermal growth factor receptor family members, the overexpression of c-erbB-1 and c-erbB-2 was retrospectively investigated in 146 southern Iranian gastric cancer patients. Indirect immunostaining was used to evaluate the expression of these two receptors in formalin-fixed paraffin-embedded tissue samples. c-ErbB-1 expression was observed in 47 (32.2%) and c-erbB-2 expression was observed in 24 (16.4%) of tumors. Significant positive correlations were observed between c-erbB-1 expression and tumor size, local invasion, lymph node involvement and tumor stage. There was also a negative correlation between c-erbB-2 expression and tumor stage. These results may suggest the contribution of c-erbB-1 molecule in progression of gastric carcinomas in southern Iranian patients. Moreover, the relatively high percentage of c-erbB-2 positive tumors may provide a useful target for the immunotherapy of these cancers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • ErbB Receptors / analysis*
  • Female
  • Gene Expression Regulation, Neoplastic
  • Genes, erbB-1 / genetics*
  • Genes, erbB-2 / genetics*
  • Humans
  • Immunoenzyme Techniques
  • Intestinal Neoplasms / genetics
  • Intestinal Neoplasms / pathology*
  • Iran
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Receptor, ErbB-2 / analysis*
  • Retrospective Studies
  • Stomach Neoplasms / genetics
  • Stomach Neoplasms / pathology*

Substances

  • ErbB Receptors
  • Receptor, ErbB-2